Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aptevo Therapeutics Inc. (APVO)
USD4.57
-0.05 (-1.08%)
US NASDAQ Healthcare Biotechnology
Address
2401 4th Avenue 98121
Seattle, WA, US
Seattle, WA, US
CEO
Jeffrey G. Lamothe
Website
aptevotherapeutics.com
IPO
2016-07-20
CIK 1671584 ISIN US03835L7029
Description
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes. Beyond its lead asset, Aptevo's research pipeline encompasses several preclinical compounds. These include ALG.APV-527, an experimental bispecific ADAPTIR molecule designed to target both 4-1BB (CD137) and 5T4, a tumor-specific antigen prevalent in numerous cancer types. Another promising candidate is APVO603, a dual agonist bispecific antibody that targets both 4-1BB and OX40. The company is also advancing APVO442, a bispecific agent leveraging its ADAPTIR-FLEX platform technology to improve the precise delivery of drugs to prostate-specific membrane antigen (PSMA)-positive tumors for the treatment of prostate cancer. To further its development efforts for ALG.APV-527, Aptevo maintains a collaborative partnership and option agreement with Alligator Bioscience AB. Founded in 2016, Aptevo Therapeutics Inc. operates from its headquarters located in Seattle, Washington.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.57
-0.05 (-1.08%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
33.4K
Beta
1.69
Float Shares
1.18M
Free Float %
99.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.45% | -2.66% | +0.42% | -29.06% | -81.76% | -49.52% | -96.11% | -100.00% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
4.57
DCF (Unlevered)
5,117.86
+111,888.2%
DCF (Levered)
5,385.10
+117,736.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-22.85
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+99.7% ★ Q1'26: +99.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-6,729.4% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+311.3% Q1'26: +26,083.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.18× Q1'26: -0.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
36.43M
est: 41.00M (-11.1%)
|
14.66M
est: 27.35M (-46.4%)
|
23.07M
est: 23.00M (+0.3%)
|
—
est: 32.66M (-100.0%)
|
4.31M
est: 4.15M (+3.8%)
|
12.29M
est: 12.03M (+2.2%)
|
3.11M
est: 3.11M (+0.2%)
|
—
|
—
|
7.55M
7.55M – 7.55M
|
6.74M
6.74M – 6.74M
-10.8% YoY
|
17.74M
17.74M – 17.74M
+163.3% YoY
|
22.87M
22.87M – 22.87M
+28.9% YoY
|
70.22M
70.22M – 70.22M
+207.1% YoY
|
| EBITDA |
-64.40M
est: -8.20M (-685.3%)
|
-50.82M
est: -5.47M (-829.3%)
|
-49.28M
est: -4.60M (-971.1%)
|
-40.83M
est: -6.53M (-525.1%)
|
-26.19M
est: -830.4K (-3,053.7%)
|
-20.26M
est: -2.41M (-742.1%)
|
-27.74M
est: -621.4K (-4,364.1%)
|
-23.78M
|
-26.07M
|
1.51M
1.51M – 1.51M
|
1.35M
1.35M – 1.35M
-10.8% YoY
|
3.55M
3.55M – 3.55M
+163.3% YoY
|
4.57M
4.57M – 4.57M
+28.9% YoY
|
14.04M
14.04M – 14.04M
+207.1% YoY
|
| EBIT |
-67.76M
est: -8.20M (-726.3%)
|
-53.95M
est: -5.47M (-886.5%)
|
-51.67M
est: -4.60M (-1,023.0%)
|
-43.06M
est: -6.53M (-559.3%)
|
-27.49M
est: -830.4K (-3,210.9%)
|
-21.40M
est: -2.41M (-789.7%)
|
-28.64M
est: -621.4K (-4,509.1%)
|
-24.13M
|
-26.31M
|
1.51M
1.51M – 1.51M
|
1.35M
1.35M – 1.35M
-10.8% YoY
|
3.55M
3.55M – 3.55M
+163.3% YoY
|
4.57M
4.57M – 4.57M
+28.9% YoY
|
14.04M
14.04M – 14.04M
+207.1% YoY
|
| Net Income |
-112.42M
est: -32.98B (+99.7%)
|
6.97M
est: 2.71B (-99.7%)
|
-53.69M
est: -14.50B (+99.6%)
|
-44.70M
est: -6.73B (+99.3%)
|
-17.75M
est: -2.79B (+99.4%)
|
-28.46M
est: -2.76B (+99.0%)
|
8.03M
est: 418.09M (-98.1%)
|
-24.13M
est: -23.77M (-1.5%)
|
-25.97M
est: -275.4K (-9,328.0%)
|
-66.2K
-66.2K – -66.2K
+75.9% YoY
|
-58.9K
-58.9K – -58.9K
+11.1% YoY
|
-56.9K
-56.9K – -56.9K
+3.3% YoY
|
-6.2K
-6.2K – -6.2K
+89.1% YoY
|
62.2K
62.2K – 62.2K
+1,100.0% YoY
|
| SGA |
38.67M
est: 89.29M (-56.7%)
|
34.58M
est: 59.55M (-41.9%)
|
28.13M
est: 50.09M (-43.8%)
|
13.96M
est: 71.12M (-80.4%)
|
13.95M
est: 9.04M (+54.3%)
|
14.70M
est: 26.19M (-43.9%)
|
13.87M
est: 6.77M (+105.0%)
|
10.22M
|
11.77M
|
13.06M
13.06M – 13.06M
|
11.65M
11.65M – 11.65M
-10.8% YoY
|
30.69M
30.69M – 30.69M
+163.3% YoY
|
39.56M
39.56M – 39.56M
+28.9% YoY
|
121.48M
121.48M – 121.48M
+207.1% YoY
|
| EPS |
-45,538,416.00
est: -2,388,601.00 (-1,806.5%)
|
-17,584,638.00
est: 196,011.00 (-9,071.3%)
|
-19,578,811.00
est: -1,049,951.00 (-1,764.7%)
|
-125,727,793.00
est: -487,748.80 (-25,677.2%)
|
-5,546,028.00
est: -202,089.07 (-2,644.3%)
|
-3,557,646.00
est: -199,918.40 (-1,679.5%)
|
922,390.00
est: 30,280.80 (+2,946.1%)
|
-31,458.00
est: -30,945.60 (-1.7%)
|
-87.27
est: -87.27 (+0.0%)
|
-20.99
-20.99 – -20.99
+75.9% YoY
|
-18.65
-18.65 – -18.65
+11.1% YoY
|
-18.04
-18.04 – -18.04
+3.3% YoY
|
-1.97
-1.97 – -1.97
+89.1% YoY
|
19.70
19.70 – 19.70
+1,100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-25.59M
OE per share TTM
-3,485.35
Owner's Yield
-95,399.28%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
197.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Armistice Capital Master Fund Ltd. | 5.03M | 9.99% | — | 5.03M | — | 5.03M | CO | — | 2020-02-14 | ↗ |
| 2 | Kevin Tang | 1.76M | 39.60% | — | 1.76M | — | 10.00 | IN | United States | 2021-06-21 | ↗ |
| 3 | Tang Capital Management, LLC | 1.76M | 39.60% | — | 1.76M | — | 10.00 | OO | Delaware | 2021-06-21 | ↗ |
| 4 | Tang Capital Partners, LP | 1.76M | 39.60% | — | 1.76M | — | 10.00 | PN | Delaware | 2021-06-21 | ↗ |
| 5 | Armistice Capital, LLC | 1.73M | 9.99% | — | 1.73M | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 6 | Steven Boyd | 1.73M | 9.99% | — | 1.73M | — | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 7 | Hudson Bay Capital Management LP | 935.6K | 6.96% | — | 935.6K | — | — | PN | State of Delaware | 2024-11-08 | ↗ |
| 8 | Sander Gerber | 935.6K | 6.96% | — | 935.6K | — | — | IN | State of Delaware | 2024-11-08 | ↗ |
| 9 | RTW Investments, LP | 288.2K | 6.96% | — | 288.2K | — | 288.2K | IA, PN, OO | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 10 | Roderick Wong | 288.2K | 6.96% | — | 288.2K | — | 288.2K | HC, IN | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 11 | RTW Master Fund, Ltd. | 201.3K | 4.86% | — | 201.3K | — | 201.3K | CO | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 12 | 27-4413262 | 122.2K | 2.95% | 47.7K | — | 122.2K | — | OO | Maryland | 2020-11-27 | ↗ |
| 13 | Identification Nos. of above persons (. | 122.2K | 2.95% | 47.7K | — | 122.2K | — | IN | States | 2020-11-27 | ↗ |
| 14 | 13-3127734 | 68.7K | 1.40% | 68.7K | — | 68.7K | — | HC | Delaware | 2022-02-10 | ↗ |
| 15 | 26-0385758 | 68.7K | 1.40% | 68.7K | — | 68.7K | — | IA | Delaware | 2022-02-10 | ↗ |
| 16 | Jon M. Plexico | 18.3K | 11.00% | 18.3K | — | 18.3K | — | HC, IN | U.S.A. | 2021-02-12 | ↗ |
| 17 | Stonepine Capital Management, LLC | 18.3K | 11.00% | 18.3K | — | 18.3K | — | IA, OO | California | 2021-02-12 | ↗ |
| 18 | Stonepine Capital, L.P. | 18.3K | 11.00% | 18.3K | — | 18.3K | — | PN | Delaware | 2021-02-12 | ↗ |
| 19 | Timothy P. Lynch | 18.3K | 11.00% | 18.3K | — | 18.3K | — | HC, IN | U.S.A. | 2021-02-12 | ↗ |
| 20 | (. | — | 0.00% | — | — | — | — | IA | Delaware Limited Partnership | 2020-02-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 61.0K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
13.5K
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+13,513
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | Grant Grady III | Director | P-Purchase | A | Common Stock | 13,513 | 1.49 | 20.1K | 13,514 | D | ↗ |
| 2025-10-01 | BANK OF AMERICA CORP /DE/ | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-30 | BANK OF AMERICA CORP /DE/ | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 27 | I | ↗ |
| 2025-08-06 | White Marvin L | Director / Officer | A-Award | A | Restricted Stock Unit | 30,000 | 0.00 | — | 30,000 | D | ↗ |
| 2025-08-06 | Taylor Daphne | Officer | A-Award | A | Restricted Stock Unit | 11,500 | 0.00 | — | 11,500 | D | ↗ |
| 2025-08-06 | Niederhuber John | Director | A-Award | A | Restricted Stock Unit | 7,200 | 0.00 | — | 7,200 | D | ↗ |
| 2025-08-06 | Lamothe Jeffrey G. | Officer | A-Award | A | Restricted Stock Unit | 17,300 | 0.00 | — | 17,300 | D | ↗ |
| 2025-08-06 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 11,500 | 0.00 | — | 11,500 | D | ↗ |
| 2025-08-06 | Kunz Barbara Lopez | Director | A-Award | A | Restricted Stock Unit | 7,200 | 0.00 | — | 7,200 | D | ↗ |
| 2025-08-06 | Huebner Dirk | Officer | A-Award | A | Restricted Stock Unit | 11,500 | 0.00 | — | 11,500 | D | ↗ |
| 2025-08-06 | Harsanyi Zsolt | Director | A-Award | A | Restricted Stock Unit | 7,200 | 0.00 | — | 7,200 | D | ↗ |
| 2025-08-06 | Grant Grady III | Director | A-Award | A | Restricted Stock Unit | 7,200 | 0.00 | — | 7,200 | D | ↗ |
| 2025-08-06 | Abdun-Nabi Daniel | Director | A-Award | A | Restricted Stock Unit | 7,200 | 0.00 | — | 7,200 | D | ↗ |
| 2025-07-17 | White Marvin L | Director / Officer | M-Exempt | A | Common Stock | 10 | 0.00 | 0.01 | 12 | D | ↗ |
| 2025-07-17 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 3 | 0.00 | 0.00 | 3 | D | ↗ |
| 2025-07-17 | Niederhuber John | Director | M-Exempt | A | Common Stock | 1 | 0.00 | 0.00 | 1 | D | ↗ |
| 2025-07-17 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock (post-reverse split May ACTIVE) | 5 | 0.00 | 0.01 | 6 | D | ↗ |
| 2025-07-17 | Kwon SoYoung | Officer | M-Exempt | A | Common Stock | 3 | 0.00 | 0.00 | 4 | D | ↗ |
| 2025-07-17 | Kunz Barbara Lopez | Director | M-Exempt | D | Restricted Stock Unit | 1 | 0.00 | — | 0 | D | ↗ |
| 2025-07-17 | Harsanyi Zsolt | Director | M-Exempt | D | Restricted Stock Unit | 1 | 0.00 | — | 0 | D | ↗ |
| 2025-07-17 | Grant Grady III | Director | M-Exempt | D | Restricted Stock Unit | 1 | 0.00 | — | 0 | D | ↗ |
| 2025-07-17 | Abdun-Nabi Daniel | Director | M-Exempt | D | Restricted Stock Unit | 1 | 0.00 | — | 0 | D | ↗ |
| 2025-07-01 | Huebner Dirk | Officer | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-03-04 | Taylor Daphne | Officer | M-Exempt | D | Restricted Stock Unit | 1 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | White Marvin L | Director / Officer | M-Exempt | D | Restricted Stock Unit | 6 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 2 | 0.00 | 0.00 | 36 | D | ↗ |
| 2025-03-03 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 2 | 0.00 | — | 0 | D | ↗ |
| 2025-03-02 | White Marvin L | Director / Officer | M-Exempt | A | Common Stock | 8 | 0.00 | 0.01 | 49 | D | ↗ |
| 2025-03-02 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 2 | 0.00 | 0.00 | 17 | D | ↗ |
| 2025-03-02 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 3 | 0.00 | 0.00 | 34 | D | ↗ |
| 2025-03-02 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 2 | 0.00 | — | 2 | D | ↗ |
| 2024-08-08 | Taylor Daphne | Officer | M-Exempt | D | Restricted Stock Unit | 158 | 0.00 | — | 0 | — | ↗ |
| 2024-08-08 | Lamothe Jeffrey G. | Officer | M-Exempt | D | Restricted Stock Unit | 42 | 0.00 | — | 41 | — | ↗ |
| 2024-08-08 | Kwon SoYoung | Officer | M-Exempt | A | Common Stock | 213 | 0.00 | 0.21 | 801 | — | ↗ |
| 2024-07-17 | White Marvin L | Director / Officer | A-Award | A | Restricted Stock Unit | 22,325 | 0.00 | — | 22,325 | — | ↗ |
| 2024-07-17 | Taylor Daphne | Officer | A-Award | A | Restricted Stock Unit | 8,550 | 0.00 | — | 8,550 | — | ↗ |
| 2024-07-17 | Niederhuber John | Director | A-Award | A | Restricted Stock Unit | 925 | 0.00 | — | 925 | — | ↗ |
| 2024-07-17 | Lamothe Jeffrey G. | Officer | A-Award | A | Restricted Stock Unit | 12,825 | 0.00 | — | 12,825 | — | ↗ |
| 2024-07-17 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 8,550 | 0.00 | — | 8,550 | — | ↗ |
| 2024-07-17 | Kunz Barbara Lopez | Director | A-Award | A | Restricted Stock Unit | 925 | 0.00 | — | 925 | — | ↗ |
| 2024-07-17 | Harsanyi Zsolt | Director | A-Award | A | Restricted Stock Unit | 925 | 0.00 | — | 925 | — | ↗ |
| 2024-07-17 | Grant Grady III | Director | A-Award | A | Restricted Stock Unit | 925 | 0.00 | — | 925 | — | ↗ |
| 2024-07-17 | Abdun-Nabi Daniel | Director | A-Award | A | Restricted Stock Unit | 925 | 0.00 | — | 925 | — | ↗ |
| 2024-06-02 | Niederhuber John | Director | M-Exempt | A | Common Stock | 81 | 0.00 | 0.08 | 217 | — | ↗ |
| 2024-06-02 | Kunz Barbara Lopez | Director | M-Exempt | D | Restricted Stock Unit | 81 | 0.00 | — | 0 | — | ↗ |
| 2024-06-02 | Harsanyi Zsolt | Director | M-Exempt | A | Common Stock | 81 | 0.00 | 0.08 | 280 | — | ↗ |
| 2024-06-02 | Grant Grady III | Director | M-Exempt | D | Restricted Stock Unit | 81 | 0.00 | — | 0 | — | ↗ |
| 2024-06-02 | Abdun-Nabi Daniel | Director | M-Exempt | A | Common Stock | 81 | 0.00 | 0.08 | 277 | — | ↗ |
| 2024-06-01 | Niederhuber John | Director | M-Exempt | A | Common Stock | 7 | 0.00 | 0.01 | 136 | — | ↗ |
| 2024-06-01 | Kunz Barbara Lopez | Director | M-Exempt | A | Common Stock | 7 | 0.00 | 0.01 | 117 | — | ↗ |
| 2024-06-01 | Harsanyi Zsolt | Director | M-Exempt | A | Common Stock | 7 | 0.00 | 0.01 | 199 | — | ↗ |
| 2024-06-01 | Grant Grady III | Director | M-Exempt | A | Common Stock | 7 | 0.00 | 0.01 | 117 | — | ↗ |
| 2024-06-01 | Abdun-Nabi Daniel | Director | M-Exempt | A | Common Stock | 7 | 0.00 | 0.01 | 196 | — | ↗ |
| 2024-05-31 | Kwon SoYoung | Officer | M-Exempt | A | Common Stock | 42 | 0.00 | 0.04 | 588 | — | ↗ |
| 2024-03-04 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 1,584 | 0.00 | 1.58 | 18,411 | — | ↗ |
| 2024-03-03 | White Marvin L | Director / Officer | M-Exempt | D | Restricted Stock Unit | 9,584 | 0.00 | — | 9,584 | — | ↗ |
| 2024-03-03 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 3,667 | 0.00 | 3.67 | 37,504 | — | ↗ |
| 2024-03-03 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 3,667 | 0.00 | — | 3,667 | — | ↗ |
| 2024-03-02 | White Marvin L | Director / Officer | M-Exempt | D | Restricted Stock Unit | 12,917 | 0.00 | — | 25,833 | — | ↗ |
| 2024-03-02 | Taylor Daphne | Officer | M-Exempt | D | Restricted Stock Unit | 3,667 | 0.00 | — | 7,333 | — | ↗ |
| 2024-03-02 | Lamothe Jeffrey G. | Officer | M-Exempt | D | Restricted Stock Unit | 5,500 | 0.00 | — | 11,000 | — | ↗ |
| 2024-03-02 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 3,667 | 0.00 | — | 7,333 | — | ↗ |
| 2024-01-29 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 792 | 0.00 | 0.79 | 13,160 | — | ↗ |
| 2024-01-28 | White Marvin L | Director / Officer | M-Exempt | A | Common Stock | 4,792 | 0.00 | 4.79 | 44,929 | — | ↗ |
| 2024-01-28 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 1,833 | 0.00 | 1.83 | 28,337 | — | ↗ |
| 2023-08-09 | Niederhuber John | Director | M-Exempt | D | Restricted Stock Unit | 3,571 | 0.00 | — | 0 | — | ↗ |
| 2023-08-09 | Kunz Barbara Lopez | Director | M-Exempt | D | Restricted Stock Unit | 3,571 | 0.00 | — | 0 | — | ↗ |
| 2023-08-09 | Harsanyi Zsolt | Director | M-Exempt | D | Restricted Stock Unit | 3,571 | 0.00 | — | 0 | — | ↗ |
| 2023-08-09 | Grant Grady III | Director | M-Exempt | D | Restricted Stock Unit | 3,571 | 0.00 | — | 0 | — | ↗ |
| 2023-08-09 | Abdun-Nabi Daniel | Director | M-Exempt | D | Restricted Stock Unit | 3,571 | 0.00 | — | 0 | — | ↗ |
| 2023-08-08 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 6,945 | 0.00 | 6.95 | 12,368 | — | ↗ |
| 2023-08-08 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 1,833 | 0.00 | 1.83 | 26,504 | — | ↗ |
| 2023-08-08 | Kwon SoYoung | Officer | M-Exempt | A | Common Stock | 9,375 | 0.00 | 9.38 | 16,708 | — | ↗ |
| 2023-06-02 | Niederhuber John | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2023-06-02 | Kunz Barbara Lopez | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2023-06-02 | Harsanyi Zsolt | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2023-06-02 | Grant Grady III | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2023-06-02 | Abdun-Nabi Daniel | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2023-06-01 | Niederhuber John | Director | M-Exempt | A | Common Stock | 297 | 0.00 | 0.30 | 2,111 | — | ↗ |
| 2023-06-01 | Kunz Barbara Lopez | Director | M-Exempt | D | Restricted Stock Unit | 297 | 0.00 | — | 298 | — | ↗ |
| 2023-06-01 | Harsanyi Zsolt | Director | M-Exempt | A | Common Stock | 297 | 0.00 | 0.30 | 4,904 | — | ↗ |
| 2023-06-01 | Grant Grady III | Director | M-Exempt | D | Restricted Stock Unit | 297 | 0.00 | — | 298 | — | ↗ |
| 2023-06-01 | Abdun-Nabi Daniel | Director | M-Exempt | A | Common Stock | 297 | 0.00 | 0.30 | 4,768 | — | ↗ |
| 2023-05-31 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 1,834 | 0.00 | — | 1,833 | — | ↗ |
| 2023-03-04 | Taylor Daphne | Officer | M-Exempt | A | Common Stock | 1,583 | 0.00 | 1.58 | 5,423 | — | ↗ |
| 2023-03-03 | White Marvin L | Director / Officer | M-Exempt | D | Restricted Stock Unit | 9,582 | 0.00 | — | 19,168 | — | ↗ |
| 2023-03-03 | Taylor Daphne | Officer | — | D | Stock Option (right to buy) | 839 | 8.56 | 7.2K | 0 | — | ↗ |
| 2023-03-03 | Lamothe Jeffrey G. | Officer | M-Exempt | D | Restricted Stock Unit | 3,666 | 0.00 | — | 7,334 | — | ↗ |
| 2023-03-03 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 11,000 | 0.00 | — | 11,000 | — | ↗ |
| 2023-01-29 | White Marvin L | Officer | M-Exempt | A | Common Stock | 4,791 | 0.00 | — | 30,555 | — | ↗ |
| 2023-01-29 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 1,834 | 0.00 | — | 9,026 | — | ↗ |
| 2022-08-09 | Niederhuber John | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2022-08-09 | Lamothe Jeffrey G. | Officer | A-Award | A | Restricted Stock Unit | 23,958 | 0.00 | — | 23,958 | — | ↗ |
| 2022-08-09 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 18,750 | 0.00 | — | 18,750 | — | ↗ |
| 2022-08-09 | Kunz Barbara Lopez | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2022-08-09 | Harsanyi Zsolt | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2022-08-09 | Grant Grady III | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2022-08-09 | Abdun-Nabi Daniel | Director | A-Award | A | Restricted Stock Unit | 3,571 | 0.00 | — | 3,571 | — | ↗ |
| 2022-06-07 | White Marvin L | Officer | A-Award | A | Restricted Stock Unit | 28,750 | 0.00 | — | 28,750 | — | ↗ |
| 2022-06-07 | Lamothe Jeffrey G. | Officer | A-Award | A | Restricted Stock Unit | 11,000 | 0.00 | — | 11,000 | — | ↗ |
| 2022-06-07 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 11,000 | 0.00 | — | 11,000 | — | ↗ |
| 2022-06-01 | Niederhuber John | Director | M-Exempt | A | Common Stock | 298 | 0.00 | 0.30 | 1,814 | — | ↗ |
| 2022-06-01 | Kwon SoYoung | Officer | M-Exempt | D | Restricted Stock Unit | 1,833 | 0.00 | — | 3,667 | — | ↗ |
| 2022-06-01 | Kunz Barbara Lopez | Director | M-Exempt | D | Restricted Stock Unit | 298 | 0.00 | — | 595 | — | ↗ |
| 2022-06-01 | Harsanyi Zsolt | Director | M-Exempt | A | Common Stock | 298 | 0.00 | — | 4,607 | — | ↗ |
| 2022-06-01 | Grant Grady III | Director | M-Exempt | D | Restricted Stock Unit | 298 | 0.00 | — | 595 | — | ↗ |
| 2022-06-01 | Abdun-Nabi Daniel | Director | M-Exempt | A | Common Stock | 298 | 0.00 | — | 8,108 | — | ↗ |
| 2022-03-04 | White Marvin L | Officer | A-Award | A | Stock Option (right to buy) | 28,750 | 0.00 | — | 28,750 | — | ↗ |
| 2022-03-04 | Lamothe Jeffrey G. | Officer | A-Award | A | Stock Option (right to buy) | 11,000 | 0.00 | — | 11,000 | — | ↗ |
| 2022-03-04 | Kwon SoYoung | Officer | A-Award | A | Stock Option (right to buy) | 11,000 | 0.00 | — | 11,000 | — | ↗ |
| 2022-01-29 | White Marvin L | Director / Officer | M-Exempt | A | Common Stock | 4,792 | 0.00 | 4.79 | 25,764 | — | ↗ |
| 2022-01-29 | Lamothe Jeffrey G. | Officer | M-Exempt | A | Common Stock | 1,833 | 0.00 | 1.83 | 7,192 | — | ↗ |
| 2021-12-03 | El-Hibri Fuad | Director | J-Other | A | Common Stock | 7,373 | 0.00 | — | 7,373 | — | ↗ |
| 2021-11-23 | TANG KEVIN C | — | S-Sale | D | Common Stock | 161,336 | 13.52 | 2.18M | 760,000 | — | ↗ |
| 2021-11-22 | TANG KEVIN C | 10% Owner | S-Sale | D | Common Stock | 16,667 | 7.36 | 122.7K | 1,160,000 | — | ↗ |
| 2021-11-19 | TANG KEVIN C | 10% Owner | S-Sale | D | Common Stock | 183,333 | 7.52 | 1.38M | 1,176,667 | — | ↗ |
| 2021-11-18 | TANG KEVIN C | 10% Owner | S-Sale | D | Common Stock | 169,533 | 8.09 | 1.37M | 1,390,467 | — | ↗ |
| 2021-06-01 | Niederhuber John | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-06-01 | Kwon SoYoung | Officer | A-Award | A | Restricted Stock Unit | 5,500 | 0.00 | — | 5,500 | — | ↗ |
| 2021-06-01 | Kunz Barbara Lopez | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-06-01 | Harsanyi Zsolt | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-06-01 | Grant Grady III | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-06-01 | El-Hibri Fuad | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-06-01 | Abdun-Nabi Daniel | Director | A-Award | A | Restricted Stock Unit | 893 | 0.00 | — | 893 | — | ↗ |
| 2021-05-24 | Kwon SoYoung | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-29 | White Marvin L | Director / Officer | A-Award | A | Restricted Stock Unit | 14,375 | 0.00 | — | 14,375 | — | ↗ |
| 2021-01-29 | Lamothe Jeffrey G. | Officer | A-Award | A | Restricted Stock Unit | 5,500 | 0.00 | — | 5,500 | — | ↗ |
| 2021-01-29 | Gross Jane A | Officer | A-Award | A | Restricted Stock Unit | 5,500 | 0.00 | — | 5,500 | — | ↗ |
| 2020-11-06 | TANG KEVIN C | 10% Owner | P-Purchase | A | Common Stock | 2,650 | 23.87 | 63.3K | 1,760,000 | — | ↗ |
| 2020-11-05 | TANG KEVIN C | 10% Owner | P-Purchase | A | Common Stock | 8,482 | 20.94 | 177.6K | 1,585,723 | — | ↗ |
| 2020-11-04 | TANG KEVIN C | 10% Owner | P-Purchase | A | Common Stock | 160,000 | 13.83 | 2.21M | 640,000 | — | ↗ |
| 2020-07-27 | White Marvin L | Director / Officer | D-Return | D | Stock Option (right to buy) | 5,414 | 27.44 | 148.6K | 0 | — | ↗ |
| 2020-07-27 | Niederhuber John | Director | A-Award | A | Stock Option (right to buy) | 170 | 8.56 | 1.5K | 170 | — | ↗ |
| 2020-07-27 | Maddux Randy Joe | Officer | D-Return | D | Stock Option (right to buy) | 4,814 | 21.28 | 102.4K | 0 | — | ↗ |
| 2020-07-27 | Lamothe Jeffrey G. | Officer | D-Return | D | Stock Option (right to buy) | 2,407 | 27.44 | 66.0K | 0 | — | ↗ |
| 2020-07-27 | Kunz Barbara Lopez | Director | A-Award | A | Stock Option (right to buy) | 1,322 | 8.56 | 11.3K | 1,322 | — | ↗ |
| 2020-07-27 | Harsanyi Zsolt | Director | D-Return | D | Stock Option (right to buy) | 892 | 30.10 | 26.8K | 0 | — | ↗ |
| 2020-07-27 | Gross Jane A | Officer | A-Award | A | Stock Option (right to buy) | 2,140 | 8.56 | 18.3K | 2,140 | — | ↗ |
| 2020-07-27 | Grant Grady III | Director | A-Award | A | Stock Option (right to buy) | 1,322 | 8.56 | 11.3K | 1,322 | — | ↗ |
| 2020-07-27 | El-Hibri Fuad | Director | A-Award | A | Stock Option (right to buy) | 1,322 | 8.56 | 11.3K | 1,322 | — | ↗ |
| 2020-07-27 | Abdun-Nabi Daniel | Director | A-Award | A | Stock Option (right to buy) | 1,322 | 8.56 | 11.3K | 1,322 | — | ↗ |
| 2020-07-02 | Niederhuber John | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-07-02 | Kunz Barbara Lopez | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-07-02 | Harsanyi Zsolt | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-07-02 | Grant Grady III | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-07-02 | El-Hibri Fuad | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-07-02 | Abdun-Nabi Daniel | Director | A-Award | A | Stock Option (right to buy) | 3,571 | 9.18 | 32.8K | 3,571 | — | ↗ |
| 2020-02-18 | White Marvin L | Director / Officer | A-Award | A | Stock Option (right to buy) | 303,200 | 0.50 | 151.0K | 303,200 | — | ↗ |
| 2020-02-18 | Mitchell Shawnte | Officer | A-Award | A | Stock Option (right to buy) | 134,800 | 0.50 | 67.1K | 134,800 | — | ↗ |
| 2020-02-18 | Maddux Randy Joe | Officer | A-Award | A | Stock Option (right to buy) | 134,800 | 0.50 | 67.1K | 134,800 | — | ↗ |
| 2020-02-18 | Lamothe Jeffrey G. | Officer | A-Award | A | Stock Option (right to buy) | 134,800 | 0.50 | 67.1K | 134,800 | — | ↗ |
| 2020-02-18 | Gross Jane A | Officer | A-Award | A | Stock Option (right to buy) | 134,800 | 0.50 | 67.1K | 134,800 | — | ↗ |
| 2020-02-18 | Adelman Michael | Officer | A-Award | A | Stock Option (right to buy) | 134,800 | 0.50 | 67.1K | 134,800 | — | ↗ |
| 2019-11-01 | White Marvin L | Director / Officer | A-Award | A | Stock Option (right to buy) | 189,894 | 0.58 | 109.4K | 189,894 | — | ↗ |
| 2019-11-01 | Mitchell Shawnte | Officer | A-Award | A | Stock Option (right to buy) | 120,968 | 0.58 | 69.7K | 120,968 | — | ↗ |
| 2019-11-01 | Maddux Randy Joe | Officer | A-Award | A | Stock Option (right to buy) | 122,359 | 0.58 | 70.5K | 122,359 | — | ↗ |
| 2019-11-01 | Lamothe Jeffrey G. | Officer | A-Award | A | Stock Option (right to buy) | 135,384 | 0.58 | 78.0K | 135,384 | — | ↗ |
| 2019-11-01 | Gross Jane A | Officer | A-Award | A | Stock Option (right to buy) | 122,982 | 0.58 | 70.8K | 122,982 | — | ↗ |
| 2019-11-01 | Adelman Michael | Officer | A-Award | A | Stock Option (right to buy) | 114,247 | 0.58 | 65.8K | 114,247 | — | ↗ |
| 2019-08-16 | Maddux Randy Joe | Officer | P-Purchase | A | Common Stock | 25,000 | 0.76 | 19.0K | 75,000 | — | ↗ |
| 2019-08-12 | El-Hibri Fuad | Director | P-Purchase | A | Common Stock | 100,000 | 0.76 | 75.5K | 1,124,536 | — | ↗ |
| 2019-07-29 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 55,015 | 0.83 | 45.9K | 1,024,536 | — | ↗ |
| 2019-07-23 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 0.90 | 9.0K | 969,521 | — | ↗ |
| 2019-07-22 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 30,000 | 0.89 | 26.6K | 959,521 | — | ↗ |
| 2019-07-19 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 26,460 | 0.90 | 23.7K | 929,521 | — | ↗ |
| 2019-07-18 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 14,404 | 0.87 | 12.6K | 903,061 | — | ↗ |
| 2019-07-17 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 19,136 | 0.87 | 16.7K | 888,657 | — | ↗ |
| 2019-07-16 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 11,375 | 0.85 | 9.7K | 869,521 | — | ↗ |
| 2019-07-11 | El-Hibri Fuad | Director / 10% Owner | P-Purchase | A | Common Stock | 14,691 | 0.85 | 12.5K | 858,146 | — | ↗ |
| 2019-07-10 | El-Hibri Fuad | Director | P-Purchase | A | Common Stock | 18,919 | 0.85 | 16.1K | 843,455 | — | ↗ |
| 2019-06-25 | Abdun-Nabi Daniel | Director | P-Purchase | A | Common Stock | 16,667 | 0.90 | 15.0K | 109,351 | — | ↗ |
| 2019-06-14 | White Marvin L | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.88 | 44.0K | 293,603 | — | ↗ |
| 2019-06-14 | Niederhuber John | Director | P-Purchase | A | Common Stock | 714 | 0.91 | 649.74 | 1,516 | — | ↗ |
| 2019-06-10 | Kunz Barbara Lopez | Director | P-Purchase | A | Common Stock | 10,000 | 0.85 | 8.5K | 10,000 | — | ↗ |
| 2019-06-07 | Harsanyi Zsolt | Director | P-Purchase | A | Common Stock | 50,000 | 0.78 | 39.0K | 50,000 | — | ↗ |
| 2019-06-01 | Niederhuber John | Director | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-06-01 | Kunz Barbara Lopez | Director | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-06-01 | Harsanyi Zsolt | Director | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-06-01 | Grant Grady III | Director | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-06-01 | El-Hibri Fuad | Director / 10% Owner | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-06-01 | Abdun-Nabi Daniel | Director | A-Award | A | Option (right to buy) | 25,000 | 0.73 | 18.1K | 25,000 | — | ↗ |
| 2019-05-31 | Maddux Randy Joe | Officer | P-Purchase | A | Common Stock | 20,000 | 0.73 | 14.6K | 50,000 | — | ↗ |
| 2019-05-21 | Grant Grady III | Director | P-Purchase | A | Common Stock | 10,000 | 0.80 | 8.0K | 10,000 | — | ↗ |
| 2019-05-20 | White Marvin L | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 0.81 | 24.3K | 243,603 | — | ↗ |
| 2019-05-14 | White Marvin L | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.78 | 7.8K | 213,603 | — | ↗ |
| 2019-03-01 | Stromatt Scott C | Officer | M-Exempt | D | Restricted Stock Unit | 16,269 | 0.00 | — | 0 | — | ↗ |
| 2019-03-01 | Mitchell Shawnte | Officer | M-Exempt | D | Restricted Stock Unit | 6,787 | 0.00 | — | 0 | — | ↗ |
| 2019-03-01 | Lamothe Jeffrey G. | Officer | M-Exempt | D | Restricted Stock Unit | 7,318 | 0.00 | — | 0 | — | ↗ |
| 2019-03-01 | Gross Jane A | Officer | M-Exempt | A | Common Stock | 9,138 | 0.00 | — | 112,293 | — | ↗ |
| 2019-03-01 | Adelman Michael | Officer | M-Exempt | A | Common Stock | 7,318 | 0.00 | — | 72,821 | — | ↗ |
| 2019-02-28 | White Marvin L | Director / Officer | A-Award | A | Stock Option (right to buy) | 151,600 | 1.52 | 230.4K | 151,600 | — | ↗ |
| 2019-02-28 | Stromatt Scott C | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2019-02-28 | Mitchell Shawnte | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2019-02-28 | Maddux Randy Joe | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2019-02-28 | Lamothe Jeffrey G. | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2019-02-28 | Gross Jane A | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2019-02-28 | Adelman Michael | Officer | A-Award | A | Stock Option (right to buy) | 67,400 | 1.52 | 102.4K | 67,400 | — | ↗ |
| 2018-12-06 | Maddux Randy Joe | Officer | P-Purchase | A | Common Stock | 5,000 | 2.37 | 11.9K | 30,000 | — | ↗ |
| 2018-12-04 | White Marvin L | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 2.38 | 23.8K | 203,603 | — | ↗ |
| 2018-08-09 | Mitchell Shawnte | Officer | M-Exempt | A | Common Stock | 1,630 | 0.00 | — | 76,135 | — | ↗ |
Executive team
Top executives
Shares Outstanding
1.18M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Marvin L. White Chief Executive Officer and President | 575.0K | — | 4.4K | — | 316.3K | 10.4K | 906.0K | 0.49% | ↗ |
| 2 | 2024 | Jeffrey G. Lamothe Executive Vice President and Chief Operating Officer | 480.0K | — | 1.9K | — | 216.0K | 10.4K | 708.3K | 0.27% | ↗ |
| 3 | 2024 | SoYoung Kwon Senior Vice President, General Counsel, Business Development and Corporate Affairs | 450.0K | — | 1.3K | — | 180.0K | 10.4K | 641.7K | 0.21% | ↗ |
| 4 | 2023 | Marvin L. White Chief Executive Officer and President | 565.1K | — | 32.1K | — | 266.4K | 9.9K | 873.4K | 3.67% | ↗ |
| 5 | 2023 | Jeffrey G. Lamothe Executive Vice President and Chief Operating Officer | 469.8K | — | 19.1K | — | 242.8K | 9.9K | 741.6K | 2.57% | ↗ |
| 6 | 2023 | SoYoung Kwon Senior Vice President, General Counsel, Business Development and Corporate Affairs | 424.6K | — | 15.4K | — | 204.9K | 9.9K | 654.7K | 2.35% | ↗ |
| 7 | 2022 | Marvin L. White Chief Executive Officer and President | 565.1K | — | 278.3K | — | 318.6K | 9.2K | 1.17M | 23.76% | ↗ |
| 8 | 2022 | Jeffrey G. Lamothe Executive Vice President and Chief Operating Officer | 459.7K | — | 252.6K | — | 222.5K | 9.2K | 944.0K | 26.76% | ↗ |
| 9 | 2022 | SoYoung Kwon Senior Vice President, General Counsel, Business Development and Corporate Affairs | 404.7K | — | 187.5K | — | 174.2K | 9.2K | 775.5K | 24.18% | ↗ |
| 10 | 2021 | Marvin L. White Chief Executive Officer and President | 565.1K | — | 1.93M | — | 296.8K | 8.7K | 2.80M | 68.87% | ↗ |
| 11 | 2021 | Jeffrey G. Lamothe Executive Vice President and Chief Operating Officer | 419.7K | — | 737.0K | — | 162.1K | 8.7K | 1.33M | 55.52% | ↗ |
| 12 | 2021 | Jeffrey G. Lamothe Executive Vice President and Chief Financial Officer | 419.7K | — | 737.0K | — | 162.1K | 8.7K | 1.33M | 55.52% | ↗ |
| 13 | 2021 | Jane Gross, Ph.D. Former Senior Vice President and Chief Scientific Officer | 342.4K | 166.0K | 737.0K | — | — | 6.8K | 1.25M | 58.86% | ↗ |
| 14 | 2021 | SoYoung Kwon Senior Vice President, General Counsel, Business Development and Corporate Affairs | 220.6K | 75.0K | 575.3K | — | 87.7K | — | 958.6K | 60.02% | ↗ |
| 15 | 2021 | SoYoung Kwon Senior Vice President, General Counsel, Corporate Affairs and Human Resources | 220.6K | 75.0K | 575.3K | — | 87.7K | — | 958.6K | 60.02% | ↗ |
| 16 | 2020 | Marvin L. White Chief Executive Officer and President | 497.7K | — | 111.6K | — | 353.2K | 8.6K | 971.1K | 11.49% | ↗ |
| 17 | 2020 | Jeffrey G. Lamothe Executive Vice President and Chief Financial Officer | 354.9K | — | 54.9K | — | 201.5K | 8.6K | 619.8K | 8.86% | ↗ |
| 18 | 2020 | Jane Gross, Ph.D. Former Senior Vice President and Chief Scientific Officer | 322.4K | 20.0K | 54.6K | — | 183.0K | 8.6K | 588.5K | 9.28% | ↗ |
| 19 | 2019 | Marvin L. White Chief Executive Officer and President | 547.3K | 224.1K | — | 194.3K | — | 8.4K | 974.1K | 19.95% | ↗ |
| 20 | 2019 | Jeffrey G. Lamothe Senior Vice President and Chief Financial Officer | 390.2K | 135.2K | — | 107.4K | — | 8.4K | 641.2K | 16.75% | ↗ |
| 21 | 2019 | Jane Gross, Ph.D. Senior Vice President and Chief Scientific Officer | 354.5K | 122.8K | — | 102.3K | — | 8.4K | 587.9K | 17.39% | ↗ |
| 22 | 2018 | Marvin L. White Chief Executive Officer and President | 565.1K | 213.3K | — | 318.1K | — | 8.3K | 1.10M | 28.79% | ↗ |
| 23 | 2018 | Scott C. Stromatt, M.D. Senior Vice President and Chief Medical Officer | 420.8K | 138.0K | — | 141.4K | — | 8.6K | 708.9K | 19.95% | ↗ |
| 24 | 2018 | Jeffrey G. Lamothe Senior Vice President and Chief Financial Officer | 402.9K | 139.4K | — | 141.4K | — | 8.3K | 692.0K | 20.44% | ↗ |
| 25 | 2018 | Jane Gross, Ph.D. Senior Vice President and Chief Scientific Officer | 366.0K | 120.0K | — | 141.4K | — | 9.0K | 636.4K | 22.22% | ↗ |
| 26 | 2017 | Marvin L. White Chief Executive Officer and President | 543.4K | 290.7K | — | 206.2K | — | 8.1K | 1.05M | 19.67% | ↗ |
| 27 | 2017 | Scott C. Stromatt, M.D. Senior Vice President and Chief Medical Officer | 412.6K | 170.8K | — | 91.7K | — | 8.1K | 683.1K | 13.42% | ↗ |
| 28 | 2017 | Jeffrey G. Lamothe Senior Vice President and Chief Financial Officer | 387.4K | 183.6K | — | 91.7K | — | 8.1K | 670.8K | 13.67% | ↗ |
| 29 | 2016 | Marvin L. White Chief Executive Officer and President | 222.3K | 238.9K | — | 385.8K | — | 123.1K | 970.1K | 39.77% | ↗ |
| 30 | 2016 | Scott C. Stromatt, M.D. Senior Vice President and Chief Medical Officer | 186.0K | 144.9K | 390.7K | — | — | 2.2K | 723.8K | 53.98% | ↗ |
| 31 | 2016 | Jeffrey G. Lamothe Senior Vice President and Chief Financial Officer | 157.7K | 153.5K | 149.0K | — | — | 101.8K | 562.0K | 26.51% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marvin L. White | Executive Chair | 1M | male |
| Jeffrey G. Lamothe | President, Chief Executive Officer & Director | 1M | male |
| SoYoung Kwon | Corporate Secretary, Senior Vice President, General Counsel, Business Development & Corporate Affairs | 904.4K | female |
| Daphne L. Taylor | Senior Vice President & Chief Financial Officer | — | female |
| Dirk Huebner | Senior Vice President & Chief Medical Officer | — | — |
| Miriam Weber Miller | Vice President of Investor Relations & Corporate Communications | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2019-06-24 | 2019-07-03 | Steve Cohen | TN09 | — | Sale (Full) | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for APVO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
